InvestorsHub Logo
Followers 0
Posts 798
Boards Moderated 0
Alias Born 07/27/2018

Re: None

Thursday, 09/27/2018 9:35:48 AM

Thursday, September 27, 2018 9:35:48 AM

Post# of 41320
Looks like ConforMIS slammed dunked on Smith & Nephew on patent lawsuits recently. How does this effect Amedica? Well one Bal is a consultant for Conformis hips. Unless you live under a rock any implant company realizes the added value Amedicas material licensed IP can offer. This is a Financial and market share windfall for Conformis who seems to be taking market share away hand over fist. When looking specifically to bless the hands of the doctors with your tech in an ever changing market it would be foolish to align your future prospects too directly with the future prospects of another company. You might just be tying yourself down to a sinking ship. Unless your focus is poor and too near sighted, you may be focused on a cash lump sum and sacrifice the macrocosm for the microcosm. That's my take on it. Why limit yourself? If dr's want to use H1 product design or the custom fit IP of Conformis? Should their choice be limited by materials? For the sake of technological advancement and humanity I don't think their choices should be limited by company or competition. If a surgeon wants H1 SiNi Custom fit the companies should be forced by the government to get along with each other enough to make that happen. This is like a basketball team that wants to shove each other around in an attempt to grand stand on the court playing on a world stage of organized teams.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News